Intraplaque hemorrhage

被引:77
作者
Levy, A. P.
Moreno, P. R.
机构
[1] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
[2] Mt Sinai Sch Med, Michale A Wiener Cardiovasc Inst, New York, NY USA
[3] Mt Sinai Sch Med, Marie Josee & Henry R Kravis Cardiovasc Hlth Ctr, New York, NY USA
关键词
D O I
10.2174/156652406778018626
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Intraplaque hemorrhage is a common feature of atherosclerotic plaques and is considered one of the identifying features of complex lesions preceding acute ischemic events. The cause of intraplaque hemorrhage is most often secondary to rupture of neovessels, which have invaded the plaque. However, inflammation and metabolic factors such as diabetes may also precipitate hemorrhage from mature microvessels by damaging the endothelium. The mechanism by which hemorrhage destabilizes the plaque is in large part secondary to the action of hemoglobin released from red blood cells at the site of the hemorrhage. Hemoglobin is a potent pro-inflammatory agent by virtue of its ability to promote formation of ROS. The major defense mechanism against the toxic effects of extracorpuscular hemoglobin is the protein haptoglobin, which tightly binds to hemoglobin and prevents it from catalyzing oxidative reactions. There exists a common allelic polymorphism in the haptoglobin gene, which has recently been strongly associated with the risk of cardiovascular disease in multiple independent cohorts. The protein products of the two different haptoglobin alleles differ in their ability to serve as an antioxidant against hemoglobin and also to activate the CD163 receptor. This review presents a unifying hypothesis whereby the haptoglobin genotype is proposed to modulate the response to intraplaque hemorrhage and thereby play a fundamental role in determining the morphological and metabolic features of complex plaques preceding acute ischemic events.
引用
收藏
页码:479 / 488
页数:10
相关论文
共 76 条
[1]   Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction [J].
Arbustini, E ;
Dal Bello, B ;
Morbini, P ;
Burke, AP ;
Bocciarelli, M ;
Specchia, G ;
Virmani, R .
HEART, 1999, 82 (03) :269-272
[2]   Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo [J].
Asleh, R ;
Guetta, J ;
Kalet-Litman, S ;
Miller-Lotan, R ;
Levy, AP .
CIRCULATION RESEARCH, 2005, 96 (04) :435-441
[3]   Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease [J].
Asleh, R ;
Marsh, S ;
Shilkrut, M ;
Binah, O ;
Guetta, J ;
Lejbkowicz, F ;
Enav, B ;
Shehadeh, N ;
Kanter, Y ;
Lache, O ;
Cohen, O ;
Levy, NS ;
Levy, AP .
CIRCULATION RESEARCH, 2003, 92 (11) :1193-1200
[4]  
Aviram M, 2001, METHOD ENZYMOL, V335, P244
[5]   Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL [J].
Bamm, VV ;
Tsemakhovich, VA ;
Shaklai, M ;
Shaklai, N .
BIOCHEMISTRY, 2004, 43 (13) :3899-3906
[6]   RUPTURE OF CORONARY VASA VASORUM AS A TRIGGER OF ACUTE MYOCARDIAL-INFARCTION [J].
BARGER, AC ;
BEEUWKES, R .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (16) :G41-G43
[7]   HYPOTHESIS - VASA VASORUM AND NEOVASCULARIZATION OF HUMAN CORONARY-ARTERIES - A POSSIBLE ROLE IN THE PATHO-PHYSIOLOGY OF ATHEROSCLEROSIS [J].
BARGER, AC ;
BEEUWKES, R ;
LAINEY, LL ;
SILVERMAN, KJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (03) :175-177
[8]  
Bernard DR, 1997, EUR J CLIN CHEM CLIN, V35, P85
[9]  
BOWMAN BH, 1982, ADV HUM GENET, V12, P189
[10]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820